A Meta-analysis of Therapeutic Effect of Thalidomide on Ankylosing Spondylitis

Source:
By:Yukun Yao, Xin Liu

DOI: https://doi.org/10.30564/jams.v3i3.2271

Abstract:

Objective: To study the therapeutic effect of thalidomide on ankylosing spondylitis (AS) by meta-analysis. Methods: Personal digital library, Cochrane library, and China Biology Medicine disc (CMBdisc), as well as relevant pharmaceutical and medical journals, were collected and reviewed. After the analysis of characteristics of the selected document and the evaluation of the risk of bias, the therapeutic effect of thalidomide on ankylosing spondylitis (AS) and its influence on related indexes were analyzed by literature data. Results: The meta-analysis results of 8 pieces of literature showed that the total effective rate of thalidomide in the treatment of ankylosing spondylitis (AS) was significantly improved, compared with conventional treatment or sulfasalazine (SASP) treatment (P＜0.05). Furthermore, the time of morning stiffness, BASDAI score, C-reactive protein (CRP) level, and other related symptoms and indexes were significantly optimized (P＜0.05). Conclusion: By rational utilization of thalidomide in the treatment of ankylosing spondylitis (AS), related symptoms and indexes of patients can be effectively improved, the total effective rate of the treatment was significantly improved and the safety of the treatment can be guaranteed.

References:

[1] XIE DH. Discussion on the therapeutic effect of thalidomide on patients with ankylosing spondylitis[J]. The Medical Forum, 2020, 24(17):2405-2406. DOI: 10.19435/j.1672-1721.2020.17.021 [2] WANG Z, ZHAO XY, QUAN BT, HUANG GQ. Efficacy and safety of thalidomide in the treatment of ankylosing spondylitis[J]. Clinical Research and Practice, 2019(14):30-32. DOI:CNKI:SUN:YLYS.0.2019-14-012 [3] RAN J. Observation of therapeutic effect of thalidomide on ankylosing spondylitis[J]. Contemporary Medical Symposium, 2019 (01):137-138. DOI:10.3969/j.issn.2095-7629.2019.01.105 [4] HOU T. Analysis of the therapeutic effect of thalidomide on ankylosing spondylitis [J]. Henan Medical Research, 2018 (04):662-663. [5] ZENG XL. Analysis of long-term efficacy and safety of thalidomide in the treatment of ankylosing spondylitis[J]. Journal of Qiqihar Medical College, 2017 (20):2412-2414. [6] GUI YL, SHI LP, XUN W, LIU ZD, HAN D, LI TR. Observation of efficacy and safety of thalidomide in the treatment of ankylosing spondylitis[J]. Modern Diagnosis and Treatment, 2017 (18):3382-3384. DOI:10.3969/j.issn.1001-8174.2017.18.029 [7] LI GK, YUAN Y. Analysis of the efficacy of thalidomide on ankylosing spondylitis [J]. China Practical Medicine, 2016 (23):1-3. DOI: 10.14163/j.cnki.11-5547/r.2016.23.001 [8] LI YH, TAO LH, QIAN KW. Clinical efficacy of thalidomide on ankylosing spondylitis and its effect on the expression of inflammatory factors[J]. Shanxi Medical Journal, 2016 (03):247-249. DOI: 10.3969/j.issn.0253-9926.2016.03.002